Alzheimer DiseasePhase 3NCT06585787
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
A Phase 3 study testing KarXT in people with Alzheimer Disease, run by Karuna Therapeutics, Inc., a Bristol Myers Squibb company at 296 sites in 25 countries.
Trial summary
The purpose of this study is to evaluate the safety and efficacy of KarXT in adult participants with mild to severe Alzheimer's Disease (AD) with moderate to severe psychosis related to AD. Read more about this study
- Who is it for?
- Ages 55 to 90 years
- Conditions the study is for
- Alzheimer Disease
- What is being tested?
- KarXT
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 406 participants
- Where
- 296 sitesin 25 countries
- Study dates
- 26 Sep 2024to 22 Dec 2026
- Phase
- Phase 3
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 55 to 90 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patients who are 55 to 90 years of age, inclusive, at the time of Screening (Visit 1).
- Patients who are diagnosed with AD based on the 2024 revised criteria for diagnosis and staging of AD: Alzheimer's Association Workgroup.
- Patient must have a magnetic resonance imaging (MRI) or computed tomography (CT) scan of the brain (completed within the past 5 years) taken during or subsequent to the onset of dementia to rule out other central nervous system (CNS) disease that could account for the dementia syndrome, eg, major stroke, neoplasm, subdural hematoma.
- Patient must have a history of psychotic symptoms (meeting International Psychogeriatric Association criteria) for at least 2 months prior to Screening (Visit 1) (participants may or may not have symptoms of agitation).
Who cannot join
- Patients will not be able to participate if they have:
- Psychotic symptoms that are primarily attributable to a condition other than the AD causing the dementia, eg, schizophrenia, schizoaffective disorder, delusional disorder, or mood disorder with psychotic features.
- History of major depressive episode with psychotic features during the 12 months prior to Screening, or history of bipolar disorder, schizophrenia, or schizoaffective disorder.
- Patients are not able to participate if they have certain safety concerns, including certain laboratory test irregularities.
- Other protocol-defined Inclusion/Exclusion criteria apply.
Trial locations and contacts
296 sites in 25 countries. Contact the study team or a site near you to ask about taking part.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com contact
First line of the email MUST contain NCT # and Site #. contact
296 sites in 25 countries
United States102 sites, 52 recruiting
- Recruiting
Advanced Research Center, Inc.
Anaheim, California, 92805-5854
Steven Macina, Site 1104, 714-999-6688
- Recruiting
Agile Clinical Research Trials, LLC
Atlanta, Georgia, 30328-5532
Vasundhara Cheekati, Site 1206, 404-382-8660
- Completed
Local Institution - 1225
Atlantis, Florida, 33462
- Recruiting
Senior Adults Specialty Research
Austin, Texas, 78757-7566
John Bertelson, Site 1263, 512-407-8628
- Recruiting
Northwest Clinical Research Center
Bellevue, Washington, 98007-4879
Wisam Al Jumaili, Site 1253, 425-453-0404
- Recruiting
McLean Hospital
Belmont, Massachusetts, 02478-1064
Arkadiy Stolyar, Site 1223, 617-855-2136
- Recruiting
Neurobehavioral Medicine Group (NBMG)
Bloomfield Township, Michigan, 48302-1909
Richard Jackson, Site 1248, 412-916-2425
- Recruiting
Envision Trials LLC
Bonita Springs, Florida, 34134
Daniel Mandri, Site 1020, 305-819-2909
- Recruiting
Tufts Medical Center - 800 Washington St - PPDS
Boston, Massachusetts, 02111-1552
Brent Forester, Site 1245, 617-636-3202
- Completed
Local Institution - 1227
Chandler, Arizona, 85224
- Recruiting
Inland Psychiatric Medical Group (IPMG)-Chino
Chino, California, 91710
Nandita Puchakayala, Site 1244, 909-488-9116
- Not yet recruiting
Local Institution - 1265
Cleveland, Ohio, 44195
Site 1265
- Not yet recruiting
Local Institution - 1267
Columbia, South Carolina, 29203-8004
Site 1267
- Recruiting
Ohio State University
Columbus, Ohio, 43221
Douglas Scharre, Site 1201, 614-293-4560
- Active, not recruiting
Local Institution - 1138
Cutler Bay, Florida, 33189-1230
- Not yet recruiting
Local Institution - 1260
Dallas, Texas, 75231-6079
Site 1260
- Not yet recruiting
Local Institution - 1258
Dayton, Ohio, 45417-3445
Site 1258
- Recruiting
Arrow Clinical Trials
Daytona Beach, Florida, 32117-5532
David Billmeier, Site 1023, 386-278-8000
- Completed
Local Institution - 1224
Deerfield Beach, Florida, 33442
- Recruiting
Epic Medical Research LLC - DeSoto
DeSoto, Texas, 75115-2043
Haresh Boghara, Site 1121, 972-777-6956
- Active, not recruiting
Local Institution - 1164
Doral, Florida, 33122-1620
- Recruiting
Advanced Neuro Research Center - El Paso
El Paso, Texas, 79912-1743
Aamr Herekar, Site 1208, 915-974-2200
- Recruiting
University of Connecticut Health Center
Farmington, Connecticut, 06030
Neha Jain, Site 1222, 860-790-7354
- Recruiting
Precise Research Centers
Flowood, Mississippi, 39232
Joseph Kwentus, Site 1132, 601-420-5810
- Not yet recruiting
Local Institution - 1262
Fort Worth, Texas, 76104-4143
Site 1262
- Recruiting
Gilbert Neurology Partners - PLLC - Avacare
Gilbert, Arizona, 85297
Jonathan Hodgson, Site 1247, 602-761-9631
- Recruiting
Triad Clinical Trials - 515 College Rd
Greensboro, North Carolina, 27410-3311
Richard Montgomery, Site 1221, 336-235-0991
- Not yet recruiting
Local Institution - 1264
Gulf Breeze, Florida, 32561
Site 1264
- Active, not recruiting
Local Institution - 1120
Hialeah, Florida, 33012-4648
- Completed
Local Institution - 1237
Hialeah, Florida, 33013
- Active, not recruiting
Local Institution - 1229
Homestead, Florida, 33030
- Not yet recruiting
Local Institution - 1261
Houston, Texas, 77030-1312
Site 1261
- Recruiting
Insight Clinical Trials LLC - Independence
Independence, Ohio, 44131
Mark Stillman, Site 1249, 216-444-8897
- Recruiting
University Hills Clinical Research - 102 Decker Ct
Irving, Texas, 75062-2898
Mary Ann Knesevich, Site 1259, 972-717-6262
- Withdrawn
Local Institution - 1254
Kirkland, Washington, 98034
- Completed
Local Institution - 1040
Lady Lake, Florida, 32159
- Completed
Local Institution - 1230
Long Beach, California, 90805
- Recruiting
USC - The Memory and Aging Center (MAC) - Alzheimer Disease Research Center (ADRC)
Los Angeles, California, 90033-5313
Lon Schneider, Site 1226, 323-442-3715
- Withdrawn
Local Institution - 1219
Los Angeles, California, 90095
- Recruiting
AMC Research, LLC - Flourish - PPDS
Matthews, North Carolina, 28105-8336
Mohammad Bolouri, Site 1214, 704-364-4000
- Active, not recruiting
Local Institution - 1159
Miami, Florida, 33032
- Active, not recruiting
Local Institution - 1021
Miami, Florida, 33122-1335
- Active, not recruiting
Local Institution - 1125
Miami, Florida, 33135-1601
- Active, not recruiting
Local Institution - 1236
Miami, Florida, 33135-2968
- Active, not recruiting
Local Institution - 1115
Miami, Florida, 33135
- Completed
Local Institution - 1010
Miami, Florida, 33137
- Completed
Local Institution - 1143
Miami, Florida, 33145-2455
- Active, not recruiting
Local Institution - 1113
Miami, Florida, 33155-6630
- Active, not recruiting
Local Institution - 1129
Miami, Florida, 33165-3947
- Active, not recruiting
Local Institution - 1150
Miami, Florida, 33165
- Active, not recruiting
Local Institution - 1006
Miami, Florida, 33173-1474
- Active, not recruiting
Local Institution - 1111
Miami, Florida, 33173
- Completed
Local Institution - 1158
Miami, Florida, 33175
- Completed
Local Institution - 1235
Miami, Florida, 33176-1451
- Completed
Local Institution - 1147
Miami, Florida, 33176-7947
- Active, not recruiting
Local Institution - 1234
Miami, Florida, 33176
- Completed
Local Institution - 1105
Miami, Florida, 33179-2537
- Active, not recruiting
Local Institution - 1157
Miami, Florida, 33184-1412
- Active, not recruiting
Local Institution - 1126
Miami Gardens, Florida, 33056-4000
- Completed
Local Institution - 1209
Miami Lakes, Florida, 33014
- Active, not recruiting
Local Institution - 1118
Miami Lakes, Florida, 33016
- Withdrawn
Local Institution - 5005
Morehead City, North Carolina, 28557
- Recruiting
West Clinical Research
Morehead City, North Carolina, 28557
Patrick Morgante, Site 1215, 252-515-0050
- Recruiting
Aqualane Clinical Research
Naples, Florida, 34105
William Justiz, Site 1246, 941-436-6838
- Recruiting
Vanderbilt Psychiatric Hospital
Nashville, Tennessee, 37212-3133
Jo Wilson, Site 1211, 615-322-4967
- Recruiting
Mid Hudson Medical Research PLLC
New Windsor, New York, 12553-7754
Sashi Makam, Site 1251, 845-674-9398
- Recruiting
Boston Neuro Research Center
North Dartmouth, Massachusetts, 02747-2612
Mushtaque Chachar, Site 1243, 508-925-7403
- Recruiting
Sensible HealthCare, LLC
Ocoee, Florida, 34761-2964
Kelly Taylor, Site 1212, 407-654-2724
- Recruiting
The Rivus Wellness & Research Institute
Oklahoma City, Oklahoma, 73112
Marvin Peyton, Site 1016, 405-317-5783
- Completed
Local Institution - 1001
Orange, California, 92866
- Completed
Local Institution - 1228
Orange, California, 92868-2847
- Recruiting
Charter Research Orlando
Orlando, Florida, 32803
Diana Balsalobre, Site 1257
- Recruiting
Nova Psychiatry
Orlando, Florida, 32803
David Medina, Site 1242, 407-823-8421
- Recruiting
Combined Research Orlando Phase I-IV LLC
Orlando, Florida, 32807-3555
Eric Carbonell, Site 1112, 407-440-4493
- Active, not recruiting
Local Institution - 1204
Ormond Beach, Florida, 32174-3101
- Active, not recruiting
Local Institution - 1043
Pasadena, California, 91106
- Recruiting
Banner Alzheimer's Institute
Phoenix, Arizona, 85006-2528
Ganesh Gopalakrishna, Site 1217, 602-839-6900
- Completed
Local Institution - 1238
Plano, Texas, 75093-8225
- Active, not recruiting
Local Institution - 1205
Port Orange, Florida, 32127-5169
- Recruiting
Alzheimer's Disease and Memory Disorders Center at Rhode Island Hospital
Providence, Rhode Island, 02903
Chuang-Kuo Wu, Site 1218, 714-456-7002
- Active, not recruiting
Local Institution - 1213
Rancho Cucamonga, California, 91730
- Not yet recruiting
Local Institution - 1266
Salem, Virginia, 24153-6404
Site 1266
- Recruiting
Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases
San Antonio, Texas, 78229-3901
Antonio Teixeira, Site 1210, 210-567-8229
- Completed
Local Institution - 1220
Scottsdale, Arizona, 85260-6742
- Withdrawn
Local Institution - 1252
Shelby, North Carolina, 28150-3803
- Completed
Local Institution - 1250
South Dartmouth, Massachusetts, 02747
- Recruiting
Elixia Health - Springfield - Elixia - PPDS
Springfield, Massachusetts, 01103
Susan Smiga, Site 1239, 413-305-1142
- Recruiting
Tekton Research, LLC - Saint Louis Psychiatry - PPDS
St Louis, Missouri, 63128
Ernest Graypel, Site 1255, 314-594-7785
- Completed
Local Institution - 1134
Stafford, Texas, 77477-3929
- Completed
Local Institution - 1133
Sweetwater, Florida, 33182
- Withdrawn
Local Institution - 1231
Syracuse, New York, 13203
- Recruiting
SUNY Upstate Medical University
Syracuse, New York, 13210-2306
Tinatin Chabrashvili, Site 1240, 617-636-5000
- Active, not recruiting
Local Institution - 1123
Tampa, Florida, 33614-2869
- Recruiting
Guardian Angel Research
Tampa, Florida, 33614
Sadaf Bazargan, Site 1124, 813-300-3300
- Recruiting
Interventional Psychiatry of Tampa Bay
Tampa, Florida, 33629-5837
Jamie Fernandez, Site 1110, 813-251-1800
- Recruiting
Charter Research
The Villages, Florida, 32162-2698
Jeffrey Norton, Site 1256, 352-775-1000
- Recruiting
Advanced Memory Research Institute - CenExel - PPDS
Toms River, New Jersey, 08755
Arun Singh, Site 1202, 732-341-9500
- Active, not recruiting
Local Institution - 1232
Toms River, New Jersey, 08755
- Recruiting
Conquest Research, LLC - Virginia - Vienna
Vienna, Virginia, 22182
Henry Tran, Site 1241, 703-717-7755
- Withdrawn
Local Institution - 1233
Wellington, Florida, 33414
- Recruiting
Premiere Research Institute at Palm Beach Neurology, PA
West Palm Beach, Florida, 33407-3209
Paul Winner, Site 1216, 561-845-0500
- Recruiting
Five Towns Neurology, PC
Woodmere, New York, 11598-1739
David Steiner, Site 1025, 516-239-1800
Japan26 sites, 16 recruiting
- Withdrawn
Local Institution - 7515
Fukuoka, 815-0082
- Completed
Local Institution - 7518
Hachiōji, Tokyo, 193-0811
- Recruiting
Hatano Kousei Hospital
Hadano, Kanagawa, 257-0003
Yoshiro Sakai, Site 7505, +81-463-77-1108
- Recruiting
Hyogo Prefectural Harima-Himeji General Medical Center
Himeji-Shi, Hyōgo, 672-8044
Kenichi Shimada, Site 7526
- Recruiting
Funairi nou clinic
Hiroshima, 730-0844
Tomoko Murakami, Site 7516
- Completed
Local Institution - 7503
Iizuka, Fukuoka, 820-0014
- Withdrawn
Local Institution - 7510
Kanzaki-Gun Yoshinogari-Cho, Saga-ken, 842-0192
- Recruiting
Koukan Clinic
Kawasaki-Shi, Kanagawa, 210-0852
Yasuhiro Yoshii, Site 7507, 81443668900
- Recruiting
Southern TOHOKU Medical Clinic
Kōriyama, Fukushima, 963-8052
Chikako Kaneko, Site 7525, 812493454322
- Recruiting
Yuge Neuropsychiatric Hospital
Kumamoto, 861-8002
Masahiro Shono, Site 7524, 81-96-338-3838
- Recruiting
National Hospital Organization Utano National Hospital
Kyoto, Kyoto, 616-8255
Shinji Sudoh, Site 7511, 81-75-461-5121
- Recruiting
Asakayama General Hospital
Sakai, Osaka, 590-0018
Kazue Kamae, Site 7509, 0722294882
- Completed
Local Institution - 7522
Sapporo, Hokkaido, 006-8555
- Recruiting
Sangenjaya Nakamura Mental Clinic
Setagaya-Ku, Tokyo, 154-0004
Satoshi Nakamura, Site 7521
- Recruiting
Kurumi Clinic
Setagaya-Ku, Tokyo, 156-0041
Chika Nishimura, Site 7519, 81333277462
- Recruiting
Tokyo Metropolitan Matsuzawa Hospital
Setagaya-Ku, Tokyo, 156-0057
Kenichi Oshima, Site 7528, 81333037211
- Completed
Local Institution - 7514
Takamatsu, Kagawa-ken, 760-0065
- Recruiting
Shin-Abuyama Hospital
Takatsuki, Osaka, 569-1041
Kazushige Morimoto, Site 7501, 8.1726931881E10
- Recruiting
Tsutsujimental Hospital
Tatebayashi, 374-0037
Hajime Tabuchi, Site 7523, 81276802111
- Recruiting
Memory Clinic Toride
Toride-shi, Ibaraki, 302-0004
Youshun Boku, Site 7508, +297796166
- Completed
Local Institution - 7506
Tsu, Mie-ken, 514-1101
- Completed
Local Institution - 7504
Wako-Shi, Saitama, 351-0102
- Completed
Local Institution - 7520
Yokohama, Kanagawa, 230-0074
- Recruiting
Yokohama City Minato Red Cross Hospital
Yokohama, Kanagawa, 2310801
Takuya Ohkubo, Site 7502, 0456286100
- Recruiting
Yokohama City University Hospital
Yokohama, Kanagawa, 236-0004
Keiko Ide, Site 7513, 81457872800
- Completed
Local Institution - 7512
Yoshinogawa, Tokushima, 776-8585
China22 sites, 21 recruiting
- Recruiting
China-Japan Friendship Hospital
Beijing, Beijing Municipality, 100025
Dantao Peng, Site 7004, 8613910908579
- Recruiting
Beijing Anding Hospital Capital Medical University
Beijing, Beijing Municipality, 100088
Qinge Zhang, Site 7005, 8613811591959
- Recruiting
Beijing Hospital
Beijing, Beijing Municipality, 100730
Haibo Chen, Site 7025, 8613910000000
- Recruiting
Xiangya Hospital Central South University
Changsha, 410008
Lu Shen, Site 7027, 073189753041
- Recruiting
West China Hospital Sichuan University
Chengdu, Sichuan, 610000
Weihong Kuang, Site 7002, +861898060171
- Recruiting
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, 400016
Yang Lv, Site 7015, +861361823653
- Withdrawn
Local Institution - 7008
Guangzhou, Guangdong, 0
- Recruiting
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, 510120
Jiehao Zhao, Site 7016, +861355619953
- Recruiting
Sir Run Run Shaw Hospital Zhejiang University School of Medicine - Qiantang Campus
Hangzhou, Zhejiang, 310009
Wei Chen, Site 7020, +86 138 0573 6335
- Recruiting
Zhejiang Hospital - Lingyin Campus
Hangzhou, Zhejiang, 310013
Xiaoli Liu, Site 7021, +865718798737
- Recruiting
Zhejiang Provincial People's Hospital
Hangzhou, Zhejiang, 310014
Zhengluan Liao, Site 7006, 13958024692
- Recruiting
First Affiliated Hospital of Kunming Medical University
Kunming, 650032
Jin Lu, Site 7022, 8613530000000
- Recruiting
The Second Affiliated Hospital of Nanjing Medical University - Main Campus
Nanjing, Jiangsu, 210011
Meijiang Feng, Site 7013, 8618951762651
- Recruiting
Nanjing Brain Hospital
Nanjing, Jiangsu, 210029
Weiwei Jiang, Site 7024, 13372003816
- Recruiting
The Affiliated Kangning Hospital of Ningbo University - Zhuangshi Campus
Ningbo, Zhejiang, 315201
Haihang Yu, Site 7030, +861360588018
- Recruiting
Shanghai Mental Health Center - PPDS
Shanghai, Shanghai Municipality, 200030
Xia Li, Site 7001, +861377427254
- Recruiting
Tongji Hospital of Tongji University
Shanghai, Shanghai Municipality, 200065
Xijin Wang, Site 7028
- Not yet recruiting
Local Institution - 7026
Shanghai, Shanghai Municipality, 200233
Site 7026
- Recruiting
Shenzhen Kangning Hospital
Shenzhen, Guangdong, 518118
Yongjun Wang, Site 7003, 8613632587615
- Recruiting
Tianjin Anding Hospital(Tianjin mental Health Center)
Tianjin, Tianjin Municipality, 300222
Daliang Sun, Site 7019, +8615122889423
- Recruiting
The Mental Health Center of Xi'an
Xi'an, Shan1xi, 710061
Wei Dang, Site 7029
- Recruiting
Affiliated Hospital of Jiangsu University
Zhenjiang, Jiangsu, 212001
Ming Yu, Site 7023, 8613860000000
South Korea13 sites, 12 recruiting
- Completed
Local Institution - 7214
Ansan-si, Gyeonggido, 15355
- Recruiting
Hallym University Chuncheon Sacred Heart Hospital
Gangwon-do, 200-704
Do-Hoon Kim, Site 7218, 821041512959
- Recruiting
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi, 03080
Manho Kim, Site 7206, +82-2-2072-2193
- Recruiting
Samsung Medical Center
Seoul, Seoul Teugbyeolsi, 06351
Hong Jin Jeon, Site 7210, 82234103586
- Recruiting
The Catholic University of Korea, Seoul St. Mary's Hospital
Seoul, Seoul Teugbyeolsi, 06591
Dong Woo Kang, Site 7217, 82200000000
- Recruiting
Ewha Womans University Seoul Hospital
Seoul, Seoul Teugbyeolsi, 07804
Jee Hyang Jeong, Site 7213, +821090851927
- Recruiting
Ewha Womans University Mokdong Hospital
Seoul, Seoul Teugbyeolsi, 7985
Geon Ha Kim, Site 7215, 82226505298
- Recruiting
Gangnam Severance Hospital, Yonsei University Health System
Seoul, 06273
Hanna Cho, Site 7219
- Recruiting
SMG - SNU Boramae Medical Center
Seoul, 07071
Jun-Young Lee, Site 7203, 8228702462
- Not yet recruiting
Local Institution - 1-14KMN4SY
Seoul, 143-729
Site 1-14KMN4SY
- Recruiting
Hanyang University Seoul Hospital
Seoul, 4763
Hee Jin Kim, Site 7211, +82222908374
- Recruiting
The Catholic University of Korea, Yeouido St. Mary's Hospital
Yeongdeungpo-gu, Seoul Teugbyeolsi, 07345
Hyun-Kook Lim, Site 7212
- Recruiting
Yongin Severance Hospital, Yonsei University Health System
Yongin-si, Gyeonggido, 16995
Woo Jung Kim, Site 7216, +8218991004
Poland10 sites, 5 recruiting
- Recruiting
Uniwersyteckie Centrum Kliniczne w Gdansku - Smoluchowskiego 17
Gdansk, Pomeranian Voivodeship, 80-214
Adam Wlodarczyk, Site 4212, 48583493720
- Withdrawn
Local Institution - 4207
Iława, Warmian-Masurian Voivodeship, 14-200
- Recruiting
Osrodek Badan Klinicznych BD Research Sp. z o.o. - Andersa 3
Iława, Warmian-Masurian Voivodeship, 14-200
Elzbieta Wagenknecht, Site 4215
- Withdrawn
Local Institution - 4213
Kielce, 25-411
- Withdrawn
Local Institution - 7527
Lodz, 91-743
- Recruiting
Pro Salus Sp. z o.o.sp. k
Lodz, 91-743
Lukasz Jasek, Site 4214
- Completed
Local Institution - 4206
Lublin, 20-064
- Recruiting
Centrum Medyczne HCP Szpital im. Jana Pawla II
Poznan, Greater Poland Voivodeship, 61-485
Przemyslaw Osip, Site 4210, 48604116632
- Recruiting
RCMed Oddzial Sochaczew
Sochaczew, 96-500
Malgorzata Fengler-Czeczko, Site 4216, +480607705818
- Completed
Local Institution - 4211
Wroclaw, 50-981
Argentina9 sites, 9 recruiting
- Recruiting
Hospital Italiano de Buenos Aires
Buenos Aires, 1199
Maria Cecilia Fernandez, Site 5002, 5411500000x00
- Recruiting
Organización Médica de Investigación
Buenos Aires, C1015ABO
Daniel Politis, Site 5009, +541150319700
- Recruiting
Fundación Para La Lucha Contra Las Enfermedades Neurológicas de La Infancia - FLENI
Buenos Aires, C1428AQK
Pablo Bagnati, Site 5006, 542234000000
- Recruiting
CINME S.A. - Centro de Investigaciones Metabólicas - Viamonte 2213/2215
Ciudad Autónoma de Buenos Aires, Buenos Aires, 1056
Griselda Russo, Site 5004, 8888888888
- Recruiting
Centro Neurobiológico y de Estrés Traumático - CENydET S.R.L.
Ciudad Autónoma de Buenos Aires, Buenos Aires, C1058AAJ
Enrique Kuper, Site 5005, 541143000000
- Recruiting
Fundación para el Estudio y Tratamiento de Enfermedades mentales- FETEM
Ciudad Autónoma de Buenos Aires, Buenos Aires, C1107
Ricardo Corral, Site 5001, 5491144455572
- Recruiting
Centro Especializado en Neurociencias - CEN
Córdoba, 5000
Hernán Ruggeri, Site 5007, +543514512141
- Recruiting
Instituto Privado Kremer
Córdoba, 5004
Leonardo Kremer, Site 5003, 543515000000
- Recruiting
Instituto Médico de la Fundación Estudios Clínicos
Rosario, Santa Fe Province, S2000DEJ
Javier Travella, Site 5008
Italy8 sites, 1 recruiting
- Recruiting
IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli
Brescia, Lombardy, 25125
Stefania Orini, Site 2324
- Completed
Local Institution - 2323
Milan, Lombardy, 20149
- Completed
Local Institution - 2307
Ponderano (Biella), Piedmont, 13875
- Completed
Local Institution - 2309
Roma, 00189
- Completed
Local Institution - 2322
Rome, Lazio, 00161
- Completed
Local Institution - 2320
Rome, Lazio, 00166
- Withdrawn
Local Institution - 2321
Rome, Roma, 00186
- Withdrawn
Local Institution - 2325
Salerno, Campania, 84131
Serbia8 sites, 6 recruiting
- Recruiting
University Clinical Center of Serbia - Dr Subotica 6 - PPDS
Belgrade, Belgrade, 11000
Tanja Stojkovic, Site 4313, 381607545958
- Recruiting
Clinical Hospital Center Dragisa Misovic Dedinje
Belgrade, 11000
Vladimir Diligenski, Site 4306, 381637708765
- Recruiting
Military Medical Academy
Belgrade, 11000
Aleksandar Eror, Site 4308, 381113609206
- Recruiting
Military Medical Academy
Belgrade, 11000
Smiljana Kostic, Site 4314, +381112663470
- Active, not recruiting
Local Institution - 4312
Gornja Toponica, 705631
- Completed
Local Institution - 4305
Kovin, 26220
- Recruiting
University Clinical Center Kragujevac
Kragujevac, 34000
Vladimir Janjic, Site 4301, +38134370208
- Recruiting
Clinical Centre of Vojvodina
Novi Sad, 21000
Marija Semnic, Site 4309, 381184601111
Spain8 sites, 7 recruiting
- Completed
Local Institution - 2212
Lleida, 25198
- Recruiting
Hospital Clinico San Carlos
Madrid, 28040
Jordi Matias Guiu, Site 2210
- Recruiting
Hospital Universitario Puerta de Hierro - Majadahonda
Majadahonda, Madrid, 28222
Pilar Sanchez Alonso, Site 2211
- Recruiting
Hospital Quironsalud Malaga
Málaga, Málaga, 29004
Jesus Romero Imbroda, Site 2213, 3495194000
- Recruiting
Hospital Universitario De Salamanca
Salamanca, 37007
Angel Montejo Gonzalez, Site 2204, +34923126580
- Recruiting
Hospital Victoria Eugenia
Seville, 41009
Felix Vinuela Fernandez, Site 2201, +34654566812
- Recruiting
Hospital Universitario Rio Hortega
Valladolid, 47012
Juan Muñoz Sanchez, Site 2203, +34679279973
- Recruiting
Hospital Viamed Montecanal
Zaragoza, 50012
Antonio Oliveros-Cid, Site 2206, +34670492099
Ukraine8 sites, 8 recruiting
- Recruiting
Municipal NonProfit Enterprise Khmelnytskyi Regional Psychiatric Care Facility of the Khmelnytskyi Regional Council
Khmelnytskyi, 32120
Viktoriia Kachynska, Site 8003, 380672624158
- Recruiting
Municipal non-profit enterprise of Lviv Regional Council Lviv Regional Clinical Psychiatric Hospital
Lviv, Lviv Oblast, 79053
Yuriy Filts, Site 8007, 380676702827
- Recruiting
Iqmed Llc
Lviv, 79035
Andriy Tsona, Site 8006, 38000000000
- Recruiting
MNE Cherkasy Regional Psychiatric Hospital of Cherkasy RC
Smila, 20708
Iryna Kosenkova, Site 8004, 380473321979
- Recruiting
MNE Ternopil Regional Clinical Psychoneurological Hospital of TRC
Ternopil, 46027
Olena Venger, Site 8008, +380677565556
- Recruiting
Neyromed LLC - Uzhhorod
Uzhhorod, 88000
Oleksandr Romaniv, Site 8005, 380509997971
- Recruiting
MI Vinnytsia Regional Psychoneurological Hospital n.a. acad. O.I. Yushchenko
Vinnytsia, Vinnytsia Oblast, 21005
Oksana Serebrennikova, Site 8002, +380679605672
- Not yet recruiting
Local Institution - 8001
Vinnytsia, Vinnytsia Oblast, Ukraine
Site 8001
Brazil7 sites, 7 recruiting
- Recruiting
L2 Ip - Instituto de Pesquisas Clinicas Ltda - ME
Brasília, Federal District, 70200-730
Eduardo Vasconcellos, Site 6201, 55-6199983-1080
- Recruiting
Ruschel Medicina
Rio de Janeiro, 22270060
Sandra Ruschel, Site 6204, 5521999822072
- Recruiting
CPQuali Pesquisa Clínica Sao Paulo
São Paulo, São Paulo, 01228-000
Leonel Takada, Site 6202, 558888888888
- Recruiting
BR Trials - Pesquisa Clínica
São Paulo, São Paulo, 01236-030
Acioly Lacerda, Site 6206, +551938639438
- Recruiting
Hospital Alemao Oswaldo Cruz (HAOC)
São Paulo, São Paulo, 01327-001
Diogo Santos, Site 6207
- Recruiting
Clinilive
São Paulo, São Paulo, 87013-250
Antonio Carlos Da Silva, Site 6203
- Recruiting
Instituto de Psiquiatria HC FMUSP
São Paulo, 05403-010
Tania Correa de Toledo Ferraz, Site 6205
India7 sites, 7 recruiting
- Recruiting
Jawaharlal Nehru Medical College, Ajmer
Ajmer, Rajasthan, 305001
Parth Singh Meena, Site 7406, 8118877284
- Not yet recruiting
Local Institution - 1-13SNAZL0
Aurangabad, Maharashtra, 431005
Site 1-13SNAZL0
- Recruiting
Postgraduate Institute of Medical Education & Research (PGIMER)
Chandigarh, Punjab, 160012
Aseem Mehra, Site 7405, +8264690790
- Recruiting
Asha Hospital - Hyderabad
Hyderabad, 500034
Chandrasekhar Kammammettu, Site 7403, 888888888
- Recruiting
Institute of Neurosciences Kolkata
Kolkata, 700017
Hrishikesh Kumar, Site 7404, 91987464544
- Recruiting
Central Institute of Behavioural Sciences
Nagpur, Maharashtra, 440010
Shailesh Pangaonkar, Site 7401, +917122548966
- Recruiting
Deva Institute of Healthcare & Research (DIHR) Pvt Ltd (Deva Institute of Healthcare)
Varanasi, 211 005
Venu Gopal Jhanwar, Site 7402, 8662444999
Romania7 sites, 6 recruiting
- Not yet recruiting
Local Institution - 4907
Bucharest, 11241
Site 4907
- Recruiting
Prof Dr Alexandru Obregia Clinical Psychiatric Hospital- Centrul de Sanatate Mintala
Bucharest, 40874
Mihaela-Cleopatra Rosca, Site 4906, +40745588989
- Recruiting
Cai Ferate Clinical Hospital Constanta
Constanța, 90123
Ana-Maria Ionescu, Site 4902, 4024151078x3
- Recruiting
Institutul Privat de Cercetări Melchisedec pentru Boli Autoimune, Ereditare și Rare -I.P.C.M
Craiova, 200157
George Badescu, Site 4903, +40762088099
- Withdrawn
Local Institution - 4905
Iași, 700282
- Recruiting
CMI Dr. Buhas Ramocea Elena Daniela - Cabinet Medical de Psihiarie
Oradea, Bihor County, 410027
Elena Daniela Buhas Ramocea, Site 4904, 0040747056934
- Recruiting
S.C. Carpe Diem SRL
Sibiu, 550281
Cosmina Muntean, Site 4901, 4026944141x5
Portugal6 sites, 1 recruiting
- Completed
Local Institution - 2701
Guimarães, Braga District, 4835-044
- Completed
Local Institution - 2704
Lisbon, Lisbon District, 1349-019
- Recruiting
ULS de Santa Maria,EPE - Hospital de Santa Maria - PPDS
Lisbon, 1649-035
Ana Verdelho, Site 2705, 3512178050x50
- Withdrawn
Local Institution - 2706
Lisbon, 1998-018
- Completed
Local Institution - 2703
Matosinhos Municipality, Porto District, 4454-509
- Completed
Local Institution - 2702
Torres Vedras, Lisbon District, 2560-280
Slovakia6 sites, 3 recruiting
- Recruiting
MUDr. Beata Dupejova - Neurologicka Ambulancia s.r.o
Banská Bystrica, 974 04
Beata Dupejova, Site 4401, +421484124549
- Recruiting
KONZILIUM s.r.o
Dubnica nad Váhom, 018 41
Magdalena Perichtova, Site 4402, +421424426231
- Recruiting
Univerzitna nemocnica L Pasteura Kosice-Rastislavova 43
Košice, Košice Region, 041 90
Slavka Dubinska, Site 4405, +421903625643
- Completed
Local Institution - 4406
Košice, 040 01
- Completed
Local Institution - 4407
Pezinok, 902 18
- Completed
Local Institution - 4403
Vranov nad Topľou, 093 01
Turkey (Türkiye)6 sites, 3 recruiting
- Recruiting
Hacettepe University Medical Faculty
Ankara, 06230
Gul Yalcin Cakmakli, Site 4706
- Completed
Local Institution - 4702
Atakum, Samsun, 55270
- Recruiting
Eskisehir Osmangazi Universitesi Tip Fakultesi Hastanesi
Eskişehir, 26040
Fatma Nazli Durmaz Celik, Site 4701, +905069093663
- Recruiting
Istanbul Universitesi Istanbul Tip Fakultesi Hastanesi
Istanbul, 34093
Hasmet Ayhan Hanagasi, Site 4704, +905322728519
- Completed
Local Institution - 4705
Izmir, 35340
- Completed
Local Institution - 4703
Izmir, 35370
Belgium5 sites
- Completed
Local Institution - 2804
Alken, 3570
- Withdrawn
Local Institution - 2807
Bruges, 8000
- Completed
Local Institution - 2806
Jette, Brussels Capital, 1090
- Completed
Local Institution - 2805
Kortrijk, 8500
- Completed
Local Institution - 2803
Roeselare, West-Vlaanderen, 8800
Bulgaria5 sites, 3 recruiting
- Recruiting
University Multiprofile Hospital for Active Treatment Sveti Georgi EAD-66 Peshtersko Shosse blvd
Plovdiv, 4001
Penka Atanasova, Site 4508
- Recruiting
University Multiprofile Hospital For Active Treatment Kanev AD
Rousse, 7002
Neli Petrova, Site 4507, 359888793906
- Completed
Local Institution - 4506
Sofia, Sofia-Grad, 1680
- Recruiting
Medical Center Medika 2005 - Branch Sofia
Sofia, 1164
Plamen Tsvetanov, Site 4509
- Withdrawn
Local Institution - 4510
Sofia, 1408
Croatia5 sites
- Completed
Local Institution - 4102
Zagreb, City of Zagreb, 10000
- Completed
Local Institution - 4105
Zagreb, City of Zagreb, 10000
- Withdrawn
Local Institution - 4106
Zagreb, City of Zagreb, 10000
- Completed
Local Institution - 4101
Zagreb, City of Zagreb, 10090
- Completed
Local Institution - 4104
Zagreb, City of Zagreb, 10090
Germany5 sites
- Withdrawn
Local Institution - 2406
Berlin, 12163
- Withdrawn
Local Institution - 2407
Böblingen, Baden-Wurttemberg, 71034
- Completed
Local Institution - 2404
Erbach im Odenwald, 64711
- Completed
Local Institution - 2405
Frankfurt am Main, 60528
- Completed
Local Institution - 2402
Homburg, Saarland, 66424
Greece5 sites, 1 recruiting
- Completed
Local Institution - 4803
Athens, Attica, 115 26
- Completed
Local Institution - 4802
Chaidari, Athens, Attica, 12462
- Recruiting
PAGNI-University General Hospital of Heraklion
Heraklion, Irakleio, 71500
Ioannis Zaganas, Site 4801, +302810394643
- Completed
Local Institution - 4810
Kalyftaki-N. Kifissia, Attica, 145 64
- Completed
Local Institution - 4811
Thessaloniki, 546 36
Hungary5 sites, 4 recruiting
- Recruiting
Semmelweis Egyetem Pszichiátriai és Pszichoterápiás Klinika
Budapest, 1083
János Réthelyi, Site 4602, +3612100336
- Recruiting
Eszak-budai Szent Janos Centrumkorhaz
Budapest, 1123
Tamás Kurimay, Site 4612, +3614584537
- Recruiting
Clinexpert Gyöngyös Kft.
Gyöngyös, Heves County, 3200
Tibor Kelemen, Site 4611, 3637312491
- Recruiting
Psychotech Kft.
Pécs, Baranya, 7633
Viktor Voros, Site 4601, +36203236939
- Withdrawn
Local Institution - 4610
Szeged, Csongrád megye, 6720
Puerto Rico5 sites, 1 recruiting
- Completed
Local Institution - 1303
Bayamón, 00961-6910
- Completed
Local Institution - 1301
Bayamón, 961
- Recruiting
Instituto De Neurologia Dra. Ivonne Fraga,Psc
San Juan, 00918-4502
Ivonne De L Fraga Berrios, Site 1302, 7874035534
- Active, not recruiting
Local Institution - 1304
San Juan, 00926-3160
- Withdrawn
Local Institution - 1305
San Juan, 00935
France4 sites, 2 recruiting
- Completed
Local Institution - 2510
Nice, Alpes-Maritimes, 06100
- Withdrawn
Local Institution - 2512
Toulouse, 31059 Cedex 9
- Recruiting
CHU de Toulouse- Gerontopole
Toulouse, 31059
Maria Eugenia Soto-Martin, Site 2513
- Recruiting
CHRU de Tours - Hôpital Bretonneau
Tours, Indre-et-Loire, 37044
Thomas Desmidt, Site 2511, 0234378952
Israel4 sites
- Completed
Local Institution - 3103
Ashkelon, Tel Aviv, 7830604
- Completed
Local Institution - 3101
Jerusalem, Jerusalem, 90000
- Completed
Local Institution - 3102
Petah Tikva, 49100
- Completed
Local Institution - 3104
Ramat Gan, 5265601
About this study
Official title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease
The purpose of this study is to evaluate the safety and efficacy of KarXT in adult participants with mild to severe Alzheimer's Disease (AD) with moderate to severe psychosis related to AD.
- Conditions
- Alzheimer Disease
- Being tested
- KarXT, Placebo
- Keywords
- Alzheimer's Disease, AD, ADEPT4, ADEPT-4, KarXT, Psychosis
- Medical subject headings
- Alzheimer Disease, Psychotic Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
KarXTDrug
Also called BMS-986510
Specified dose on specified days
PlaceboDrug
Specified dose on specified days
| Study group | Role | What they receive |
|---|---|---|
| KarXT | Experimental | Not described Receives: Drug: KarXT |
| Placebo | Experimental | Not described Receives: Drug: Placebo |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change from baseline in Neuropsychiatric Inventory-Clinician: Hallucinations and Delusions (NPI-C: H+D) score
Measured: Up to Week 14
Secondary outcomes (26)
Change from baseline in Clinical Global Impressions-Severity (CGI-S) scale
Measured: Up to Week 14
Change from baseline in Neuropsychiatric Inventory-Clinician (NPI-C) Core score: Hallucination Domain
Measured: Up to Week 14
Change from baseline in NPI-C Core score: Delusion Domain
Measured: Up to Week 14
Change from baseline in NPI-C Core score: Agitation Domain
Measured: Up to Week 14
Change from baseline in NPI-C Core score: Aggression Domain
Measured: Up to Week 14
Change from baseline in NPI-C Agitation score
Measured: Up to Week 14
Change from baseline in NPI-C Core score: Caregiver Distress Scale
Measured: Up to Week 14
Number of participants with a ≥ 40% improvement from Baseline in NPI-C: H+D score
Measured: Up to Week 14
Number of participants with Adverse Events (AEs)
Measured: Up to Week 14
Number of participants with Treatment-Emergent Adverse Events (TEAEs)
Measured: Up to Week 14
Number of participants with Serious Adverse Events (SAEs)
Measured: Up to Week 14
Number of participants with TEAEs leading to study withdrawal
Measured: Up to Week 14
Number of participants with procholinergic symptoms
Measured: Up to Week 14
Number of participants with anticholinergic symptoms
Measured: Up to Week 14
Number of participants with AEs of Special Interest (AESIs)
Measured: Up to Week 14
Barnes Akathisia Rating Scale (BARS) Score
Measured: Up to Week 14
Abnormal Involuntary Movement Scale (AIMS) Score
Measured: Up to Week 14
Body Weight
Measured: Up to Week 14
Body Mass Index (BMI)
Measured: Up to Week 14
Number of participants with vital sign abnormalities
Measured: Up to Week 14
Number of participants with clinical laboratory abnormalities
Measured: Up to Week 14
Number of participants with 12-lead electrocardiogram (ECG) abnormalities
Measured: Up to Week 14
Cognition as assessed by the Mini-Mental State Examination (MMSE)
Measured: Up to Week 14
International Prostate Symptom Score (IPSS)
Measured: Up to Week 14
Number of participants with suicidal ideation and behavior as assessed by the Columbia Suicide Severity Rating Scale (C-SSRS)
Measured: Up to Week 14
Cognition as assessed by the Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog-13)
Measured: Up to Week 14
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Sep 2024
- Study start26 Sep 2024
- Primary completion24 Nov 2026 (estimated)
- Study completion22 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Alzheimer DiseaseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 3
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind
- Who is masked
- Participant, Care provider, Investigator, Outcomes assessor
- Enrolment
- 406 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Bristol-Myers Squibb, Study director, Bristol-Myers Squibb
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06585787
- Sponsor's protocol ID
- CN012-0056
- Other IDs
- 2024-516363-92, U1111-1310-4139
- Status last verified
- Sep 2026
- First submitted
- 30 Aug 2024
- Last updated
- 22 Sep 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- Yes
- FDA-regulated device
- No
- Individual data sharing
- Yes: BMS will provide access to individual anonymized participant data upon request from qualified researchers, and subject to certain criteria. Additional information regarding Bristol Myer Squibb's data sharing policy and process can be found at https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html
Study at a glance
From the registry record, last updated by the sponsor on 22 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease
- ClinicalTrials.gov ID
- NCT06585787
- Acronym / sponsor ID
- CN012-0056
- Conditions
- Alzheimer Disease
- Keywords
- Alzheimer's Disease, AD, ADEPT4, ADEPT-4, KarXT, Psychosis
- Phase
- Phase 3
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 406 participants (estimated)
- Lead sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb companyIndustry (pharma, biotech, devices)
- Study start
- 26 Sep 2024 (actual)
- Primary completion
- 24 Nov 2026 (estimated)
- Study completion
- 22 Dec 2026 (estimated)
- First posted
- 19 Sep 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to evaluate the safety and efficacy of KarXT in adult participants with mild to severe Alzheimer's Disease (AD) with moderate to severe psychosis related to AD.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind (participant, care provider, investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| KarXT | Experimental | Drug: KarXT |
| Placebo | Experimental | Drug: Placebo |
Who may qualify
- Ages
- 55 to 90 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Patients who are 55 to 90 years of age, inclusive, at the time of Screening (Visit 1).
- Patients who are diagnosed with AD based on the 2024 revised criteria for diagnosis and staging of AD: Alzheimer's Association Workgroup.
- Patient must have a magnetic resonance imaging (MRI) or computed tomography (CT) scan of the brain (completed within the past 5 years) taken during or subsequent to the onset of dementia to rule out other central nervous system (CNS) disease that could account for the dementia syndrome, eg, major stroke, neoplasm, subdural hematoma.
- Patient must have a history of psychotic symptoms (meeting International Psychogeriatric Association criteria) for at least 2 months prior to Screening (Visit 1) (participants may or may not have symptoms of agitation).
Key exclusion criteria (5 listed)
- Patients will not be able to participate if they have:
- Psychotic symptoms that are primarily attributable to a condition other than the AD causing the dementia, eg, schizophrenia, schizoaffective disorder, delusional disorder, or mood disorder with psychotic features.
- History of major depressive episode with psychotic features during the 12 months prior to Screening, or history of bipolar disorder, schizophrenia, or schizoaffective disorder.
- Patients are not able to participate if they have certain safety concerns, including certain laboratory test irregularities.
- Other protocol-defined Inclusion/Exclusion criteria apply.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| KarXTAlso: BMS-986510Specified dose on specified days | Drug | KarXT |
| PlaceboSpecified dose on specified days | Drug | Placebo |
Primary outcome
Change from baseline in Neuropsychiatric Inventory-Clinician: Hallucinations and Delusions (NPI-C: H+D) score
Time frame: Up to Week 14
26 secondary outcomes
Change from baseline in Clinical Global Impressions-Severity (CGI-S) scale
Time frame: Up to Week 14
Change from baseline in Neuropsychiatric Inventory-Clinician (NPI-C) Core score: Hallucination Domain
Time frame: Up to Week 14
Change from baseline in NPI-C Core score: Delusion Domain
Time frame: Up to Week 14
Change from baseline in NPI-C Core score: Agitation Domain
Time frame: Up to Week 14
Change from baseline in NPI-C Core score: Aggression Domain
Time frame: Up to Week 14
Change from baseline in NPI-C Agitation score
Time frame: Up to Week 14
Change from baseline in NPI-C Core score: Caregiver Distress Scale
Time frame: Up to Week 14
Number of participants with a ≥ 40% improvement from Baseline in NPI-C: H+D score
Time frame: Up to Week 14
Number of participants with Adverse Events (AEs)
Time frame: Up to Week 14
Number of participants with Treatment-Emergent Adverse Events (TEAEs)
Time frame: Up to Week 14
Number of participants with Serious Adverse Events (SAEs)
Time frame: Up to Week 14
Number of participants with TEAEs leading to study withdrawal
Time frame: Up to Week 14
Number of participants with procholinergic symptoms
Time frame: Up to Week 14
Number of participants with anticholinergic symptoms
Time frame: Up to Week 14
Number of participants with AEs of Special Interest (AESIs)
Time frame: Up to Week 14
Barnes Akathisia Rating Scale (BARS) Score
Time frame: Up to Week 14
Abnormal Involuntary Movement Scale (AIMS) Score
Time frame: Up to Week 14
Body Weight
Time frame: Up to Week 14
Body Mass Index (BMI)
Time frame: Up to Week 14
Number of participants with vital sign abnormalities
Time frame: Up to Week 14
Number of participants with clinical laboratory abnormalities
Time frame: Up to Week 14
Number of participants with 12-lead electrocardiogram (ECG) abnormalities
Time frame: Up to Week 14
Cognition as assessed by the Mini-Mental State Examination (MMSE)
Time frame: Up to Week 14
International Prostate Symptom Score (IPSS)
Time frame: Up to Week 14
Number of participants with suicidal ideation and behavior as assessed by the Columbia Suicide Severity Rating Scale (C-SSRS)
Time frame: Up to Week 14
Cognition as assessed by the Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog-13)
Time frame: Up to Week 14
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Sep 2026.
- BMS Clinical Trial InformationLink provided by the sponsor.
- BMS Clinical Trial Patient RecruitingLink provided by the sponsor.
- Individual participant dataSharing planned: Yes. BMS will provide access to individual anonymized participant data upon request from qualified researchers, and subject to certain criteria. Additional information regarding Bristol Myer Squibb's data sharing policy and process can be found at https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html
Related trials for Alzheimer Disease
Not yet recruiting
Virtual Reality to Advance Dementia Care and Quality of Life
Dementia, Agitation
RecruitingPhase 2
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
Alzheimer's Disease
RecruitingObservational study
Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging
Aging
Recruiting
The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults Study
Obstructive Sleep Apnea, Cognitive Decline
Active, not recruiting
Promoting Physical Activity in Older Hispanic/Latino(a) Adults
Sedentary Behavior, Physical Inactivity
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com contact
First line of the email MUST contain NCT # and Site #. contact
Bristol-Myers Squibb study director
Bristol-Myers Squibb
296 sites in 25 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 3 study testing KarXT in people with Alzheimer Disease, run by Karuna Therapeutics, Inc., a Bristol Myers Squibb company at 296 sites in 25 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 22 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 296 sites in United States, Japan, China, South Korea, Poland and 20 more countries. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact BMS Clinical Trials Contact Center www.BMSClinicalTrials.com (855-907-3286, Clinical.Trials@bms.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change from baseline in Neuropsychiatric Inventory-Clinician: Hallucinations and Delusions (NPI-C: H+D) score (time frame: Up to Week 14). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Sep 2026.